The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 24, 2018

Filed:

Apr. 23, 2014
Applicant:

Optiscan Biomedical Corporation, Hayward, CA (US);

Inventors:

Michael Butler, Dublin, CA (US);

Eugene Lim, Lafayette, CA (US);

Craig Johnson, Dublin, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 39/10 (2006.01); A61B 5/15 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61B 5/1455 (2006.01); A61B 5/153 (2006.01); A61B 5/155 (2006.01); A61B 5/157 (2006.01); A61M 39/26 (2006.01);
U.S. Cl.
CPC ...
A61B 5/150992 (2013.01); A61B 5/0059 (2013.01); A61B 5/1455 (2013.01); A61B 5/14532 (2013.01); A61B 5/14546 (2013.01); A61B 5/15003 (2013.01); A61B 5/153 (2013.01); A61B 5/155 (2013.01); A61B 5/157 (2013.01); A61B 5/150229 (2013.01); A61B 5/150389 (2013.01); A61B 5/150503 (2013.01); A61B 5/150755 (2013.01); A61B 5/412 (2013.01); A61M 39/10 (2013.01); A61M 39/1011 (2013.01); A61M 39/26 (2013.01); A61B 5/14557 (2013.01); A61B 2560/0437 (2013.01); A61M 2039/1027 (2013.01); A61M 2039/1033 (2013.01); A61M 2039/263 (2013.01); A61M 2205/0222 (2013.01); A61M 2205/0238 (2013.01);
Abstract

Methods and systems for determining the concentration of one or more analytes from a sample such as blood or plasma are described. The systems described herein can be configured to withdraw a sample from a source of fluid, direct a first portion of the withdrawn sample to an analyte monitoring system and return a second portion of the sample. The analyte monitoring system can be connected to the fluid source via a connector that is configured to improve fluid flow and reduce blood clotting risk. These goals can be accomplished, for example, by employing coatings in or on a connector, positioning a resilient substance at or near the junction, by reducing dead space volume, by using resiliency to improve fit, by extending a portion of one connector to better mate with a portion of another connector, etc.


Find Patent Forward Citations

Loading…